Abstract
IgG4-related disease (IgG4-RD) is a fibro-inflammatory condition associated with tumefactive lesions at multiple sites. IgG4-RD was initially recognized in 2001 in a case of autoimmune pancreatitis. However, the disease was not limited to the pancreas but involved other organs such as the bile ducts, lacrimal glands, lymph nodes and salivary glands. IgG4-RD is rarely seen with an estimated incidence of 0.2 to 1/100.000 as reported in Japan, but with minimal to no incidence data have been published in Western countries. We hereby report a case of an IgG4-related mass arising from the nasolacrimal duct, masquerading as a sinonasal mass.
Keywords: IgG4-related disease, nasal mass, nasolacrimal mass
ÖZ
IgG4 ile ilişkili hastalık (IgG4-RD), birçok bölgede tümefaktif lezyonlarla ilişkili fibro-inflamatuar bir durumdur. IgG4-RD ilkin 2001 yılında bir otoimmün pankreatit vakasında görüldü. Ancak hastalık pancreas ile sınırlı olmayıp safra kanalları, gözyaşı bezleri, lenf düğümleri ve tükürük bezleri gibi diğer organları da kapsıyordu. IgG4-RD nadirdi, Japonya’da rapor edilen tahmini insidans 0,2 ila 1/100,000 iken, Batı ülkelerinde minimal veya hiçbir insidans verisi yoktu. Burada, nazolakrimal kanaldan kaynaklanan ve sinonazal bir kitle olarak maskelenen bir IgG4 ile ilişkili kitle olgusu sunuyoruz.
Keywords: IgG4 ile ilişkili hastalık, nazal kitle, nazolakrimal kitle
Introduction
IgG4-related disease (IgG4-RD) is a fibro-inflammatory condition associated with tumefactive lesions at multiple sites1. Hamano et al.2 first discovered IgG4-RD in 2001 by showing correlation between elevated serum IgG4 levels and chronic inflammatory lesions in the pancreas leading to autoimmune pancreatitis1. This disease is not limited to the pancreas but also involves bile ducts, lacrimal glands, lymph nodes, and salivary glands2. IgG4-RD is rarely seen disease with an estimated incidence of 0.2 to 1 per 100,000 population reported in Japan and minimal incidence data are available in Western countries2. We hereby report a case of IgG4-related mass arising from the nasolacrimal duct, masquerading as a sinonasal mass.
Case Report
A 59-year-old lady presented to us with unprovoked epistaxis coming from her left nostril, associated with left sided nose block and whitish nasal discharge for six months. She denied headache, fever, and any constitutional symptoms. On examination, rigid nasal endoscopy showed a left -sided vascularized sinonasal mass (Figure 1), that was hard in consistency and completely obstructed the left nasal vestibule. Endoscopic assessment through the right nostril showed clear nasal cavity with normal nasopharynx. Her physical examination showed intact cranial nerves with no palpable cervical lymph nodes.
Figure 1.

Image A representing the Endoscopic view of left vascularized sinonasal mass occupying the whole of left nasal vestibule. Image B representing the left nasal cavity after the mass was removed.
The clinical findings were suspicious of malignancy, therefore we proceeded with a computed tomography (CT) scan of the paranasal sinus, which showed a hypodense mass on the left anterior ethmoid sinus encasing the distal septum measuring (3.7 (AP) x 1.8 (W) x 2.4 (CC) (Figure 2), with right maxillary sinus thickening and enlarged level 1b cervical lymph node measuring 1.1 cm, and well-pneumatized bilateral frontal, sphenoid and mastoid air cells. Biopsy of the mass showed increased number of non-malignant plasma cells (positive for CD138). This finding did not correlate with her clinical presentation and imaging findings. Then, we proceeded with examination under anaesthesia and left nasal mass was excised via endoscopic sinus surgery. We observed a left nasal mass arising from the lateral wall of the left nasal cavity, just anterior to the left middle turbinate, involving the anterior one-third of the left inferior turbinate. There was a visible stump arising from the lacrimal region of the lateral nasal wall and we proceeded with excision of the tumour. The mass was excised completely and sent for histopathological examination. The patient was then discharged in good health on the next day and she was started on regular alkaline nasal douching.
Figure 2.

CT images of A-Axial view CT Paranasal sinus showing a left sided nasal mass. Note the posteromedial defect of the nasolacrimal duct. B-Coronal view of paranasal sinus, demonstrating a left nasal mass extending to the nasolacrimal duct.
The histopathological examination of the left nasal mass (Figure 3) showed fibro-inflammatory lesion that consisted of lymphohistiocytic infiltrates with background of vague storiform-like pattern fibrosis (highlighted by Mason trichrome stain), and the presence of emperipolesis (highlighted by immunohistochemical S100, CD 68 stains). Furthermore, her blood tests revealed raised serum IgG level of 2012 mg/dL. Both histopathological findings and raised serum IgG level pointed towards the diagnosis of IgG4-RD. Computed tomgraphies of thorax, abdomen and pelvis did not show any other organ involvement. She was started on systemic therapy. At six-month follow up, there was no local recurrence on repeated nasal endoscopies (Figure 2) and she has achieved complete remission.
Figure 3.

Histopathologic samples from tumour. Image A representing tissue with CD68. Image B representing tissue with Mason Trichome stain showing characteristic storiform pattern fibrosis. Image C representing S100 stain showing emperipolesis.
Discussion
Our literature review involved search results of case reports obtained from PUBMED, Google Scholar, MEDLINE and EMBASE using the keywords “sinonasal”, “nasal”, “IgG4-related disease”, and “paranasal sinus”. Case reports of isolated sinonasal IgG4-RD were collected for the time interval between 2011 and 2021 prior to the completion of the current case report. In total, 15 case reports were identified and included in our summary (Table 1). In total, 11 male and five female cases have been reported within the past 10 years with an age range of 15 to 72, with no noticeable bias towards age extremities. The mean age of presentation was 47 years with male preponderance while symptoms were highly nonspecific. Most cases were multicentric (involving more than one site in the sinonasal region) while the commonest sinus being affected by tumour was the maxillary sinus followed by the ethmoids and sphenoid sinuses. All reported cases had gone into remission after surgery and systemic immunosuppressant therapy.
Table 1.
Review of the literature.
| No | Authors | Age | Gender | Presenting symptoms | Nasal and paranasal sinus involvement | Treatment | Outcome |
|---|---|---|---|---|---|---|---|
| 1 | Alt et al 2012 [12] | 38 | Female | Headache | B/L sphenoid | Surgical debridement; topical fluticasone | Relapsed after surgery subsequently on remission |
| 2 | Sasaki et al 2012 [13] | 71 | Male | Nasal obstruction, Right facial swelling | B/L nasal cavity, maxillary sinus. Left pterygopalatine fossa | Prednisolone | Remission |
| 3 | Lindau et al 2013 [14] | 69 | Male | Right eye diplopia | Right maxillary, ethmoid, frontal sinus | Prednisolone; surgical debridement; Rituximab | Remission |
| 4 | Cain et al 2014 [15] | 62 | Female | Epistaxis | Sphenoid sinus | Prednisolone | Remission |
| 5 | Morris et al 2014 [16] | 34 | Male | Nasal obstruction | Nasal septum | Prednisolone; methotrexate | Remission |
| 6 | Prabhu et al 2014 [5] | 15 | Female | Nasal obstruction, epistaxis | Right maxillary sinus, septum | Prednisolone | Remission |
| 7 | Prabhu et al 2014 [9] | 15 | Female | Bloody rhinorrhoea, facial swelling, trismus | Right maxillary, ethmoid, sphenoid sinus, septum | Prednisolone | Remission |
| 8 | Song et al 2015 [7] | 72 | Male | Left eye proptosis, periorbital pain, post nasal drip | Left maxillary, ethmoid sinus, left orbit | Surgical debridement; prednisolone | Remission |
| 9 | Kurien et al 2015 [18] | 21 | Male | Facial pain, headache, proptosis | Maxillary sinus, pterygoid plate, orbital floor | Surgical debridement; prednisolone | Remission |
| 10 | Kojima et al 2015 [19] | 67 | Male | Nasal obstruction | Maxillary, sphenoid, frontal sinus, nasal septum | Steroid therapy | Remission |
| 11 | Vandjelovic et al 2015 [20] | 46 | Male | Epistaxis, facial pain, rhinorrhoea | Ethmoid sinus, frontal recess | Surgical debridement; prednisolone | Remission |
| 12 | Chen et al 2016 [21] | 36 | Male | Nasal pain, headache | Ethmoid sinus, middle turbinate | Surgical debridement; prednisolone | Remission |
| 13 | Gontarz et al 2016 [22] | 30 | Male | Spontaneous loss of teeth, epistaxis | Maxillary, ethmoid sinus, upper alveolar mucosa | Steroid therapy | Remission |
| 14 | Bashyam et al 2018 [17] | 71 | Male | Right cheek swelling, mild proptosis | Right maxillary sinus, nasal cavity, orbit | Prednisolone; mycophenolate | Remission |
| 15 | Kouwenberrg et al 2019 [1] | 48 | Male | Spontaneous loss of teeth, nasal pain, headache | Upper alveolar mucosa, maxillary, ethmoid sinus | Surgical debridement; prednisolone; azathioprine | Remission |
IgG4-RD is a systemic chronic inflammatory disease characterized by relapsing-remitting episodes of tumour-like lesion formations in different sites of the body. It is caused by local tissue infiltration by lymphocytes and IgG4 secreting plasma cells which often respond well to systemic steroids3,4. The site of tumour formation varies from one individual to another and can occur either metachronously or synchronously. The commonest affected organs in the head and neck regions were the salivary and lacrimal glands3,5. Nomenclatures have been developed to represent IgG4-RD at certain parts of the head and neck regions namely Mikulicz’s disease (lacrimal glands), Kuttner’s disease (submandibular glands), and eosinophilic angiocentric fibrosis (upper respiratory tract and paranasal sinuses). However, eosinophilic angiocentric fibrosis was renamed as IgG4-RD in recent years4. Diagnosis is made based on a set of diagnostic criteria set by the Japanese IgG4 team created by the Ministry of Health, Labor and Welfare (MHLW) of Japan in 2011. Its diagnostic criteria include clinical features of tumour development in single or multiple organs, increased serum IgG4 (>135 mg/dL) levels, and characteristic histopathological features6.
Our case demonstrates a unique case of isolated nasal vestibular mass which was protruding from the nostril (Figure 2) with a highly vascularized appearance (Figure 1). This appearance gave a false impression of vascular lesion arising from the nasal cavity which may represent malignancy, granulomatous lesion like Wegener’s granulomatosis or a benign vascular lesion like a haemangioma or angiofibroma. The most prudent step after clinical assessment is to perform contrasted scan (MRI or CT scan) to assess the vascularity of the tumour, followed by biopsy of the tumour to identify the pathology. The treatment for this patient was consistent with the consensus of treatment for sinonasal tumour, which is surgical excision followed by long term treatment with systemic steroids7. The outcome of this case was like most of the literature, whereby the majority had gone into remission7.
Nasal manifestation of IgG4-RD is uncommon and may masquerade chronic sinusitis7,8. Often, patients can present with concurrent orbital manifestations and may be linked to Mikulicz disease when presenting with bilateral lesions9. Our case showed a lesion arising from the right nasolacrimal duct which enlarged and subsequently occupied the entire nasal vestibule without significant local invasion into the surrounding sinuses. Histopathological assessment was straightforward due to the characteristic features seen in the diagnostic criteria such as the storiform fibrosis and obliterative phlebitis5, but no specific histological evidence of the nasolacrimal duct was seen in our samples. When compared with other cases in the literature (Table 1), symptoms were often indistinguishable and nonspecific. Surprisingly, isolated unilateral nasolacrimal duct lesions tend to grow without extensive local bony destruction compared to bilateral diseases10 which suggests that unilateral involvement may have better prognosis in sinonasal IgG4-RD.
Conclusion
This case report highlighted a rare case of IgG4-RD arising from the nasolacrimal duct and its behavior in comparison to the literature. We have showed that nasolacrimal duct tumours tend to be less locally invasive as they grew towards the nasal cavity at their early stages and respond well to systemic steroids after endoscopic excision.
References
- 1.Kouwenberg WL, Dieleman FJ, Willems SM, Rosenberg AJWP. Inflammatory pseudotumour of the alveolar process of the maxilla as clinical manifestation of IgG4-related disease: a case report and literature review. Int J Oral Maxillofac Surg. 2020;49:722–5. doi: 10.1016/j.ijom.2019.11.008. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 2.Palazzo E, Palazzo C, Palazzo M. IgG4-related disease. Joint Bone Spine. 2014;81:27–31. doi: 10.1016/j.jbspin.2013.06.001. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 3.Wallace ZS, Deshpande V, Mattoo H et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466–75. doi: 10.1002/art.39205. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Stone JH, Khosroshahi A, Deshpande V et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7. doi: 10.1002/art.34593. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Al-Khalili OM, Erickson AR. IgG-4 related disease: an introduction. Mo Med. 2018;115:253–6. PMID: 30228732. [PMC free article] [PubMed] [Google Scholar]
- 6.Umehara H, Okazaki K, Nakamura T et al. Current approach to the diagnosis of IgG4-related disease - Combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol. 2017;27:381–91. doi: 10.1080/14397595.2017.1290911. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 7.Song BH, Baiyee D, Liang J. A rare and emerging entity: Sinonasal IgG4-related sclerosing disease. Allergy Rhinol (Providence). 2015;6:151–7. doi: 10.2500/ar.2015.6.0136. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Moteki H, Yasuo M, Hamano H, Uehara T, Usami S. IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease. Acta Otolaryngol. 2011;131:518–26. doi: 10.3109/00016489.2010.533699. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Prabhu SM, Yadav V, Irodi A, Mani S, Varghese AM. IgG4-related disease with sinonasal involvement: A case series. Indian J Radiol Imaging. 2014;24:117–20. doi: 10.4103/0971-3026.134384. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Suzuki M, Mizumachi T, Morita S, Kubota K, Iizuka K. A case of immunoglobulin 4-related disease with bilateral mass-forming lesions in the nasolacrimal ducts. J Clin Rheumatol. 2011;17:207–10. doi: 10.1097/RHU.0b013e31821c71a3. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 11.Alt JA, Whitaker GT, Allan RW, Vaysberg M. Locally destructive skull base lesion: IgG4-related sclerosing disease. Allergy Rhinol (Providence) 2012;3:e41–5. doi: 10.2500/ar.2012.3.0026. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sasaki T, Takahashi K, Mineta M, Fujita T, Aburano T. Immunoglobulin G4 − Related sclerosing disease mimicking invasive tumor in the nasal cavity and paranasal sinuses. AJNR Am J Neuroradiol. 2012;33:e19–20. doi: 10.3174/ajnr.A2495. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lindau RH, Su YB, Kobayashi R, Smith RB. Immunoglobulin G4-related sclerosing disease of the paranasal sinus. Head Neck. 2013;35:E321–4. doi: 10.1002/hed.23175. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 14.Cain RB, Colby TV, Balan V, Patel NP, Lal D. Perplexing lesions of the sinonasal cavity and skull base: IgG4-related and similar inflammatory diseases. Otolaryngol Head Neck Surg. 2014;151:496–502. doi: 10.1177/0194599814533648. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 15.Morris C, Ng T, Kevin P, Singh N. Immunoglobulin G4 related disease isolated to the nasal cavity: a rare cause of nasal obstruction. J Laryngol Otol. 2015;129:S57–9. doi: 10.1017/S0022215114001911. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 16.Kurien R, Babu TR, Rupa V. Unusual cause of maxillary sinus mass with proptosis. BMJ Case Rep. 2015. 2015:bcr2015210627.[CrossRef] [DOI] [PMC free article] [PubMed]
- 17.Kojima M, Nakazato Y, Hirabayashi K, Masawa N, Nakamura N. IgG4-related plasma cell granuloma of the maxillary sinus: A report of 2 cases. Ear Nose Throat J. 2015;94:E17–9. PMID: 26401675. [PubMed] [Google Scholar]
- 18.Vandjelovic ND, Humphreys IM. Immunoglobulin G4-related sclerosing disease of the paranasal sinuses: A case report and literature review. Allergy Rhinol (Providence) 2016;7:85–9. doi: 10.2500/ar.2016.7.0154. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Chen BN. IgG4-related disease presenting with destructive sinonasal lesion mimicking malignancy. Eur Arch Otorhinolaryngol. 2016;273:4027–9. doi: 10.1007/s00405-016-4033-2. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 20.Gontarz M, Wyszynska-Pawelec G, Zapała J, Gałazka K, Tomaszewska RA, Lazar A. IgG4-related disease in the head and neck region: report of two cases and review of the literature. Pol J Pathol. 2016;67:370–5. doi: 10.5114/pjp.2016.65871. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 21.Bashyam A, Nagala S, Tahir F, Mirza S. Immunoglobulin G4-related disease of the paranasal sinuses. BMJ Case Rep. 2018. 2018:bcr-2018-224472.[CrossRef] [DOI] [PMC free article] [PubMed]
